2 Responses

  1. Jo Mason 26 January 2022 at 12:45 | | Reply

    This is a dedicated team working h to gain acceptance of use of xenlet. They also have discovered new uses for xenleta such as for CF. They just began a trial yet for another use M genitalia. Progess is slow but they are getting there. This year will be big. CHINA will approve.

  2. Adam 26 January 2022 at 20:18 | | Reply

    Thank you for the good information 👌
    I would like to hear your opinion about Nabrivias future. Do you think that company will survive all those challenges?

Leave a Reply